Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 452,095 |
|
|||||
| News | - | ||||||
| Day High | 580.00 | Low High |
|||||
| Day Low | 564.00 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Bloomsbury Publishing Plc | BMY | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -20.00 | -3.48% | 554.00 | 10:35:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 574.00 | 564.00 | 580.00 | 554.00 | 574.00 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 111 | 452,095 | 562.58p | 2,543,405p | - | 376.00 - 580.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:48:43 | O | 23,328 | 575.00p | GBX |
| Industry Sector |
|---|
| MEDIA |
Bloomsbury Publishing Plc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 457.17M | 81.06M | - | 264.1M | 20.24M | 0.25 | 22.59 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Bloomsbury Publishing News
Bloomsbury Publishing profit to top forecasts on fantasy..Bloomsbury Publishing Discussion Forums - BMY
| Date | Time | Comments | Title |
|---|---|---|---|
| 8/01/2023 | 13:23 | - | AZN pays BMY/Ono Pharma $510M to_settle_all_patent_litigation_regarding Imjudo/I |
| 7/27/2023 | 11:37 | - | BMY 2Q23 CC transcript: |
| 7/27/2023 | 07:45 | - | BMY reports 2Q23 results—cuts 2023 non-GAAP EPS guidance: |
| 7/11/2023 | 07:30 | - | Opdivo monotherapy—>statsig OS/PFS as_addend_to_cisplatin_in first-line bladder cancer: |
| 7/10/2023 | 11:59 | - | BMY opts-in for worldwide rights_to PRTA’s anti-tau compound, PRX005: |
| 6/20/2023 | 08:23 | - | GERN submits Imetelstat NDA for treatment of transfusion-dependent |
| 6/17/2023 | 12:40 | - | BMY sues US government regarding IRA: |
| 6/06/2023 | 10:43 | - | BMY’s ASCO slide set: |
| 6/04/2023 | 14:04 | - | Opdivo bests Adcetris in first-line-HL PFS—immature_OS_data_trending_in_favor_of |
| 5/30/2023 | 05:51 | - | Repotrectinib NDA has 11/27/23 PDUFA date—(with FDA priority review): |
Historical BMY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 562.00 | 580.00 | 542.00 | 559.29 | 223,344 | -8.00 | -1.42% |
| 1 Month | 551.00 | 580.00 | 510.00 | 545.59 | 134,177 | 3.00 | 0.54% |
| 3 Months | 462.50 | 580.00 | 462.50 | 533.76 | 121,515 | 91.50 | 19.78% |
| 6 Months | 385.50 | 580.00 | 385.50 | 487.62 | 111,148 | 168.50 | 43.71% |
| 1 Year | 450.00 | 580.00 | 376.00 | 457.82 | 121,215 | 104.00 | 23.11% |
| 3 Years | 285.00 | 580.00 | 285.00 | 418.98 | 132,908 | 269.00 | 94.39% |
| 5 Years | 238.00 | 580.00 | 165.00 | 348.12 | 134,023 | 316.00 | 132.77% |
